About
MedMira Inc. is a Canadian biotechnology company focused on the research, development, and commercialization of rapid diagnostic tests. Founded in 1993, the company utilizes its patented Rapid Vertical Flow® (RVF) Technology to create products that quickly and reliably detect infectious diseases, including HIV, hepatitis C, syphilis, and H. pylori. The core product line features Reveal® HIV tests, Multiplo® Complete Syphilis tests, and H. pylori antibody tests, along with the Miriad™ product line for donor suitability testing in tissue and eye banks. MedMira's products are utilized in various healthcare settings, including hospitals, laboratories, and public health agencies, and are distributed globally through a network of medical distributors and strategic partners. In addition to its diagnostic products, MedMira licenses its RVF technology to researchers and biotech companies, expanding its reach into veterinary and environmental diagnostics. The company is committed to quality, holding ISO 9001 and ISO 13485 certifications, and has received multiple awards for its innovative contributions to the field.
Technologies
Keywords
Company Information
-
Employees 20
-
Founded 1993
-
Annual Revenue $297000
-
Total Funding $4172582
Location
155 Chain Lake Drive, Halifax, Nova Scotia, Canada, B3S 1B3